일중 데이터의 기간을 직접 선택하세요. 내보내기에는 2~3분이 걸릴 수 있습니다. 이 탭을 열어두시면 다운로드가 자동으로 시작됩니다.
데이터 없음
A detailed description of the company is not yet available....
Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Glo...
Definium Therapeutics (DFTX) is back in focus after reporting positive topline results from its Phase 3 Voyage study of DT120 ODT in generalized anxiety disorder. This event has quickly refocused atte...
In August 2026, Definium Therapeutics reported that its Phase 3 Voyage trial of DT120 ODT in generalized anxiety disorder met the primary HAM-A endpoint and all key secondary measures, delivering rapi...
Definium Therapeutics (NasdaqGS: DFTX) reported positive topline data from its pivotal Phase 3 Voyage trial of DT120 ODT in adults with generalized anxiety disorder. The study met all primary and key ...
Definium Therapeutics' (DFTX) phase 3 data for DT120 in generalized anxiety disorder looked better t